A rapid detection method for apoptosis and necrosis measurement using the Cellometer imaging cytometry

Leo Li-Ying Chan1, Ning Lai, Elena Wang

  • 1Department of Technology R&D, Nexcelom Bioscience LLC, Lawrence, MA 01843, USA. lchan@nexcelom.com

Insights

This study shows Cellometer imaging cytometry can detect apoptosis and necrosis. This provides a fast, cost-effective alternative for cell death assays in drug discovery.

Area of Science:

  • Biomedical research
  • Cell biology
  • Drug discovery

Background:

  • Apoptosis and necrosis are crucial in preclinical pharmaceutical drug discovery.
  • Assessing compound cytotoxicity aids in identifying potential drug candidates.
  • Nexcelom Bioscience LLC developed a new imaging cytometry system for cell analysis.

Purpose of the Study:

  • To demonstrate Cellometer imaging cytometry for apoptosis and necrosis detection.
  • To evaluate its use as a quick, simple, and inexpensive alternative for cell death assays.
  • To compare its performance against conventional flow cytometry.

Main Methods:

  • Utilized Cellometer imaging cytometry for fluorescence-based cell death assays.
  • Studied dose-response effects of heat and drug-induced cell death in Jurkat cells.
  • Labeled cells with annexin V-FITC (apoptotic) and propidium iodide (necrotic).
  • Compared results with conventional flow cytometry.

Main Results:

  • Cellometer imaging cytometry successfully detected apoptosis and necrosis.
  • Experimental results showed similar cell population data compared to flow cytometry.
  • Demonstrated dose-response effects of cell death induction.

Conclusions:

  • Cellometer imaging cytometry is a viable method for apoptosis and necrosis detection.
  • It offers a rapid, cost-effective alternative to traditional methods, especially for smaller labs.
  • Enhances research efficiency in pharmaceutical discovery and validation.